exploration in Biological Technology

Standard & Poor's Announces Changes to U.S. Indices

... TX, the company will be added to the S&P MidCap 400 GICS Oil & Gas exploration & Production Sub-Industry index. Following is a summary of the ... Oil & Gas exploration & Production ...

Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

... by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries. It will bring together ... by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries in search of new TB treatments. ...

The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline

... by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries. It will bring together ... by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries in search of new TB treatments. ...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

... features designed to further enhance the competitive position of ANA598, including twelve weeks of triple combination treatment and a randomized exploration of shortening the overall duration of HCV therapy in conjunction with ANA598 treatment." About ANA598 ANA598 is a non-nucleoside ...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

... regimens. The upcoming Phase II trial has several important elements, including twelve weeks of ANA598 combination treatment and a randomized exploration of shortening the overall duration of HCV therapy in conjunction with ANA598 treatment. We look forward to receiving the first data from this trial ...

Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics

... and in its best-studied mode of action quashing gene expression by cleaving messenger RNA. Experimental applications of RNAi have spurred the exploration of gene function in basic research, drug discovery and clinical settings. The 2006 Nobel Prize for medicine and physiology and a number of corporate ...

Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae

... income from licensing to third parties. "This agreement between SGI and EMRE represents a comprehensive, long-term research and development exploration into the most efficient and cost effective organisms and methods to produce next generation algal biofuel," said J. Craig Venter, Founder and CEO of ...

Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM)

... products developed and validated in the Human Proteome Resource (HPR) Center. The Human Proteome Resource (HPR) Center is performing a systematic exploration of the human proteome with Affinity (Antibody) based Proteomics, combining high-throughput generation of affinity-purified (mono-specific) antibodies ...

Top CEOs Declare America's Manufacturing Sector Requires Pro-Industry Policies, Capital Management and Innovation to Maintain Economic Leadership

... in the United States: Chip McClure, CEO, ArvinMeritor: The future of manufacturing must rely on advancing through innovation, exploration and commercialization, which requires an increasingly sophisticated workforce and government policies to generate continued growth. Vikram ...

Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity

... of historical and cutting-edge research findings and biological information. From an initial search on the site, simple navigation allows for exploration of broader networks, providing insight into pathway interactions. Users can also model prospective experiments in Your Favorite Gene powered by ...

PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice

... an ARA in a model of heart failure. Dr. Sabbah stated, "This encouraging preclinical study strongly supports continued preclinical and clinical exploration of GP531 as an adjunct therapy for the treatment of acute heart failure syndromes. GP531 represents a novel cardioprotective approach with a unique ...

Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software

... in data, and filtering/highlighting based on user requirements. Visual i/o Benefits:   Facilitates faster, more-informed exploration and refinement of data, and better decision-making. Powerful interactive analysis empowers business users to easily understand complex data ...

Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement

... solutions enhance and promote everything from removing trans fats in cooking, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces. Our 5,000+ employees ...

The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program

... data taken from public repositories such as GEO. This will ultimately mean superior CNS pathway annotation and facilitate easier data analysis and exploration for our customers." About GeneGo, Inc. GeneGo, Inc. develops systems biology technology such as compound based pathway analysis , ...

Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition

... that marks San Diego as a leader in the area of scientific discovery." "Life Technologies is proud to support the JCVI team in its visionary exploration of life within our seas," said Greg Lucier, the company's Chairman and Chief Executive Officer. "We look forward to partnering with Craig on this ...

PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting

... relevant neuroscience biomarkers to achieve the goal of alleviating pain and related symptoms. Dr. Franke will discuss how this approach to enhance exploration of safety and efficacy and pharmacokinetic analysis can be applied to a broad range of psychiatry, neuropsychopharmacology, neuroimaging, and ...

Gene Network Sciences Announces Michael Gilman as Board Member

... new approaches to personalized medicine. The industry is at a crossroads, with advances in DNA sequencing finally paving the way to a more systematic exploration of disease biology and drug response markers. Data is no longer the bottleneck -- the analysis is. That's why I see technology such as GNS's as the ...

Evidence of Ancient Hot Springs on Mars Detailed in Astrobiology Journal

... paper entitled, "A Case for Ancient Springs in Arabia Terra, Mars," Carlton C. Allen and Dorothy Z. Oehler , from the Astromaterials Research and exploration Science Directorate at the NASA Johnson Space Center, Houston, Texas, propose that new image data from the High Resolution Imaging Science Experiment ...

Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity

... innovation in the use of microgravity to advance biotech, nanotech, combustion, metallurgy, and other fields. Sponsored by the Trust and Space exploration Technologies (SpaceX), the competition offers a $25,000 prize and transportation to and from Low Earth Orbit for the winning experiment aboard a ...

Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity

... molecular functions, cell regulation, protein domains, and metabolic and signaling pathways. From an initial search, simple navigation allows exploration of broader networks, providing insight into pathway interactions. Researchers can also model prospective experiments in Your Favorite Gene powered ...

ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross

... therapeutics in orphan indications or underserved subpopulation of high risk patient's through its proprietary technology of entrapment and in-depth exploration of red cell physiologic properties. ERYtech is focused in the fields of Haematology, Oncology and Metabolic Diseases. ERYtech Pharma's most ...

Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice

... Josh Schultz, Ph.D., Carolus Therapeutics' vice president of research. "Our ongoing collaboration with RWTH Aachen University involves the further exploration of chemokine interactions involved in inflammatory signaling." In addition to targeting PF4-RANTES heterodimers, Carolus Therapeutics has a ...

ADVENTRX Exploring Strategic Options

... The Company is currently in discussions with several candidates for both strategic and partnering transactions. "Publicly announcing our exploration of strategic alternatives provides the best opportunity to find a partner who wishes to acquire one or both of our late-stage oncology assets," ...

AngioGenex Reviews 2008 Achievements and Sets Goals for 2009

... a major cancer meeting in 2009. The new studies will include expanded safety and additional anti-tumor testing of AGX51 in animals as well as further exploration of the feasibility of use of our companion diagnostic for theranostic purposes. Our goal is to file an IND on AGX51 and to initiate human testing ...

'Far From Beyond': A Glimpse into the World of Biotechnology and the Future of the Free World

... ), written about a time and place that could not be too far off in the future. With the advances in biotechnology and intelligence, space exploration and a truly global marketplace, the world as we know it stands at the grasp of anyone's reach. That reach may not be embraced by the right people or ...

PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time

... held company in the Bay Area of California with presence across the world. The company took its metadata server technology to the global Oil and Gas exploration and Production industry in 2001, and has since demonstrated its relevance for business process orchestration, security, search, and compliance to the ...

Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics

... and in its best-studied mode of action quashing gene expression by cleaving messenger RNA. Experimental applications of RNAi have spurred the exploration of gene function in many basic research, drug discovery and clinical settings. The 2006 Nobel Prize for medicine and physiology and a number of ...

Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility

... BRNI was established by Rockefeller in 1999 in honor of his mother, Blanchette, who was afflicted by Alzheimer's disease. The Institute's scientific exploration of memory and memory disorders has led to recent discoveries with a drug -- Bryostatin -- shown to create new connections in the brain, among ...

Top Biopharma Company Adopts BioFortis' Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data

... Labmatrix to have a rapid and profound effect on the productivity of its Translational Medicine efforts. "Labmatrix is the only data management and exploration application on the market that is built from the ground up to support translational medicine and biomarker discovery," said Jian Wang, BioFortis ...

Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation

... system, researchers are now able to visualize, track, quantify and understand biological processes in real time-as the action happens-driving visual exploration and analysis of gene expression, cellular pathways and drug response. The IVIS Kinetic system features an isolation chamber that allows users to ...

Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights

... and achieve future milestones; the significance of such milestones; future results of clinical trials; advancement of Arena's pipeline; exploration of licensing opportunities; therapeutic indication, tolerability, side effects, efficacy and potential of Arena's or its collaborators' product ...

Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities

... commercial and industrial market. Global is a fully integrated energy company whose interests include electrical power generation, oil and gas exploration and production, clean coal and waste management technologies. This press release contains forward-looking information within the meaning of ...

ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))

... the initial marketing application for the MXP will be for bone marrow processing, both at point-of-care and in a laboratory, we will continue our exploration of the use of this technology platform for other sources of adult stem cells including mobilized peripheral blood and adipose tissue stem cell ...

Angiotech to Establish Separate Operating and Royalty Businesses

... any remaining debt. The various assets, including the royalty business and API equity stake, owned by Angiotech will also allow continued exploration of additional financing and strategic alternatives to potentially further reduce or eliminate remaining Angiotech debt. Transaction ...

VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics

... discovery and diagnostics. The focus is in investigating mechanisms of cancer development and progression, identification of therapeutic targets and exploration of the mechanism of action of anti-cancer compounds. VTT will utilize MetaCore and MetaDrug in high-throughput compound screening, RNA interference ...

PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies

... PAREXEL's dedicated clinical pharmacology services directed at alleviation of pain and related symptoms use neuroscience biomarkers to enhance exploration of safety and efficacy and pharmacokinetic analysis. This expanded approach for a broad range of psychiatry, neuropsychopharmacology, neuroimaging, ...

Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals

... will harness the power of Nuevolution's Chemetics(R) platform technology which enables both hit identification and hit-to-lead optimization by exploration of ultra large chemistry space through the screening of multiple fragment-based small molecule libraries of more than 100 million compounds per ...

LI-COR(R) Biosciences and Tiger Woods Learning Center Collaborate to Develop High School Curriculum in Genetics

... the Tiger Woods Learning Center The 14-acre, $25 million educational center represents the vision of Tiger Woods to inspire and support the career exploration of students by providing free enrichment programs in reading, math, science and technology. Specific classes promote career preparation in areas ...

Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation

... for Kendle," said President Simon Higginbotham. "The addition of DecisionLine is an important step in building Kendle's global capabilities for exploration of early phase drug candidates and supports our strategic initiative to drive growth in our Phase I business. We look forward to leveraging the ...

NASA Nanotechnology-Based Biosensor Helps Detect Biohazards

... makes use of ultra-sensitive carbon nanotubes which can detect biohazards at very low levels," explained Meyya Meyyappan, chief scientist for exploration technology and former director of the Center for Nanotechnology at Ames. "When biohazards are present, the biosensor generates an electrical signal, ...